These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1944912)

  • 1. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.
    Alderson K; Holds JB; Anderson RL
    Neurology; 1991 Nov; 41(11):1800-5. PubMed ID: 1944912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor nerve sprouting in human orbicularis muscle after botulinum A injection.
    Holds JB; Alderson K; Fogg SG; Anderson RL
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):964-7. PubMed ID: 2335457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic features of human orbicularis oculi treated with botulinum A toxin.
    Harris CP; Alderson K; Nebeker J; Holds JB; Anderson RL
    Arch Ophthalmol; 1991 Mar; 109(3):393-5. PubMed ID: 2003801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nerve innervation distribution of orbicularis oculi muscle for botulinum neurotoxin application using Sihler's method.
    Çiçek F; Çınaroğlu S; Ceranoğlu FG; Küçük E; Zor KR
    Ann Anat; 2024 Jan; 251():152165. PubMed ID: 37804929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion.
    Eleopra R; Tugnoli V; Caniatti L; De Grandis D
    Neurology; 1996 Apr; 46(4):1158-60. PubMed ID: 8780112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics.
    Horn AK; Porter JD; Evinger C
    Exp Brain Res; 1993; 96(1):39-53. PubMed ID: 8243582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening.
    Forget R; Tozlovanu V; Iancu A; Boghen D
    Neurology; 2002 Jun; 58(12):1843-6. PubMed ID: 12084888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbicularis oculi muscle graft augmentation after protractor myectomy in blepharospasm.
    Yen MT; Anderson RL; Small RG
    Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):287-96. PubMed ID: 12878877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.
    Borodic GE; Cozzolino D; Ferrante R; Wiegner AW; Young RR
    Ophthalmic Plast Reconstr Surg; 1991; 7(1):54-60. PubMed ID: 1708272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    Doc Ophthalmol; 1994; 86(4):395-402. PubMed ID: 7835177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure.
    Aramideh M; Ongerboer de Visser BW; Koelman JH; Bour LJ; Devriese PP; Speelman JD
    Mov Disord; 1994 Jul; 9(4):395-402. PubMed ID: 7969205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in the management of blepharospasm.
    Dutton JJ; Buckley EG
    Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm.
    Aramideh M; Ongerboer de Visser BW; Devriese PP; Bour LJ; Speelman JD
    Brain; 1994 Feb; 117 ( Pt 1)():27-38. PubMed ID: 8149212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB
    Schweiz Rundsch Med Prax; 1990 Nov; 79(48):1512-4. PubMed ID: 2255835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():40-3. PubMed ID: 1810207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54(5):206-9. PubMed ID: 1804034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.